Pretreatment Diffusion-Weighted MRI Can Predict the Response to Neoadjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma

Table 2

Clinicopathologic features of the responders and nonresponders.

Characteristic	Number of patients		-value
	Responders ()	Nonresponders ()
Sex
Male	58	12	1.000
Female	18	4
Age
≥50 years	26	6	0.802
<50 years	50	10
WHO pathologic type
Type 1	1	0	0.834
Type 2	7	2
Type 3	68	14
Clinical stage (2010)
III	43	9	0.997
IVA	24	5
IVB	9	2

WHO = World Health Organization.